SCHEMBL2805734

SCHEMBL2805734

OCc1cccc(Nc2ncc3c(n2)-c2ccccc2[C@H](c2ccccc2F)C3)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 3/20 0.70
FGFR2 P21802 2/20 0.70
CSF1R P07333 1/20 0.70
FGFR3 P22607 1/20 0.70
SYK P43405 1/20 0.53
CDK2 P24941 7/20 0.44
CDK9 P50750 6/20 0.44
KDR P35968 4/20 0.42
JAK2 O60674 2/20 0.41
JAK1 P23458 2/20 0.41
JAK3 P52333 1/20 0.41
PLK1 P53350 1/20 0.41
CCNA2 P20248 1/20 0.41
CCNA1 P78396 1/20 0.41
ABL1 P00519 3/20 0.40
CDK5 Q00535 1/20 0.39
CDK5R1 Q15078 1/20 0.39
EGFR P00533 1/20 0.39
PDGFRB P09619 1/20 0.39
KIT P10721 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2805735 1.00 FGFR1 (0.70) FGFR1FGFR2CSF1RFGFR3SYK
SCHEMBL2804274 0.93 FGFR1 (0.73) FGFR1FGFR2CSF1RFGFR3SYK
SCHEMBL2804096 0.93 FGFR1 (0.73) FGFR1FGFR2CSF1RFGFR3SYK
SCHEMBL19000832 0.89 FGFR1 (0.76) FGFR1FGFR2CSF1RFGFR3SYK
SCHEMBL28343974 0.88 CSF1R (0.69) FGFR1FGFR2CSF1RFGFR3SYK
SCHEMBL28343975 0.88 CSF1R (0.69) FGFR1FGFR2CSF1RFGFR3SYK
SCHEMBL2802713 0.87 FGFR1 (0.64) FGFR1FGFR2CSF1RFGFR3SYK
SCHEMBL19012094 0.86 FGFR1 (0.86) FGFR1FGFR2CSF1RFGFR3SYK
SCHEMBL28372352 0.85 FGFR1 (0.66) FGFR1FGFR2CSF1RFGFR3SYK
SCHEMBL2807779 0.85 FGFR1 (0.66) FGFR1FGFR2CSF1RFGFR3CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078421-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F] ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 FGFR1 530/4885FGFR2 511/4885CSF1R 4606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.